Cargando…
Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy
Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, imm...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545905/ https://www.ncbi.nlm.nih.gov/pubmed/34712717 http://dx.doi.org/10.3389/fcvm.2021.759119 |
_version_ | 1784590088674476032 |
---|---|
author | Alania-Torres, Edgardo Morillas-Climent, Herminio García-Escrivá, Alexandre Vinueza-Buitrón, Paul Poquet-Catalá, Inmaculada Zorio, Esther Sánchez-Lázaro, Ignacio José Galcerá-Jornet, Emilio Valle-Muñoz, Alfonso |
author_facet | Alania-Torres, Edgardo Morillas-Climent, Herminio García-Escrivá, Alexandre Vinueza-Buitrón, Paul Poquet-Catalá, Inmaculada Zorio, Esther Sánchez-Lázaro, Ignacio José Galcerá-Jornet, Emilio Valle-Muñoz, Alfonso |
author_sort | Alania-Torres, Edgardo |
collection | PubMed |
description | Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, immune system activation or exposure to drugs. Hot phases of ALVC present with chest pain and troponin rise, mimicking acute viral myocarditis and indicate a progression of the disease. Recently, myocarditis has also been described as an infrequent complication of coronavirus disease 2019 (Covid-19) mRNA vaccines. We herein report for the first time a case of probable myocarditis induced by Covid-19 vaccine in a patient with previous medical history of ALVC. We aim to highlight the common characteristics of ALVC and Covid-19 vaccine myocarditis and work through the differential diagnosis of these two entities. |
format | Online Article Text |
id | pubmed-8545905 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85459052021-10-27 Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy Alania-Torres, Edgardo Morillas-Climent, Herminio García-Escrivá, Alexandre Vinueza-Buitrón, Paul Poquet-Catalá, Inmaculada Zorio, Esther Sánchez-Lázaro, Ignacio José Galcerá-Jornet, Emilio Valle-Muñoz, Alfonso Front Cardiovasc Med Cardiovascular Medicine Arrhythmogenic left ventricular cardiomyopathy (ALVC) is a rare heritable heart-muscle disorder characterized by a progressive loss of left ventricular myocardium and its replacement by fibrofatty tissue. Myocarditis is an inflammatory disease of the heart that may occur secondary to infections, immune system activation or exposure to drugs. Hot phases of ALVC present with chest pain and troponin rise, mimicking acute viral myocarditis and indicate a progression of the disease. Recently, myocarditis has also been described as an infrequent complication of coronavirus disease 2019 (Covid-19) mRNA vaccines. We herein report for the first time a case of probable myocarditis induced by Covid-19 vaccine in a patient with previous medical history of ALVC. We aim to highlight the common characteristics of ALVC and Covid-19 vaccine myocarditis and work through the differential diagnosis of these two entities. Frontiers Media S.A. 2021-10-12 /pmc/articles/PMC8545905/ /pubmed/34712717 http://dx.doi.org/10.3389/fcvm.2021.759119 Text en Copyright © 2021 Alania-Torres, Morillas-Climent, García-Escrivá, Vinueza-Buitrón, Poquet-Catalá, Zorio, Sánchez-Lázaro, Galcerá-Jornet and Valle-Muñoz. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Alania-Torres, Edgardo Morillas-Climent, Herminio García-Escrivá, Alexandre Vinueza-Buitrón, Paul Poquet-Catalá, Inmaculada Zorio, Esther Sánchez-Lázaro, Ignacio José Galcerá-Jornet, Emilio Valle-Muñoz, Alfonso Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title | Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title_full | Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title_fullStr | Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title_full_unstemmed | Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title_short | Case Report: Probable Myocarditis After Covid-19 mRNA Vaccine in a Patient With Arrhythmogenic Left Ventricular Cardiomyopathy |
title_sort | case report: probable myocarditis after covid-19 mrna vaccine in a patient with arrhythmogenic left ventricular cardiomyopathy |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545905/ https://www.ncbi.nlm.nih.gov/pubmed/34712717 http://dx.doi.org/10.3389/fcvm.2021.759119 |
work_keys_str_mv | AT alaniatorresedgardo casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT morillasclimentherminio casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT garciaescrivaalexandre casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT vinuezabuitronpaul casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT poquetcatalainmaculada casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT zorioesther casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT sanchezlazaroignaciojose casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT galcerajornetemilio casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy AT vallemunozalfonso casereportprobablemyocarditisaftercovid19mrnavaccineinapatientwitharrhythmogenicleftventricularcardiomyopathy |